Institutional Ownership
Molecular Partners AG
CUSIP 60853G106ADSMOLNQ1 2026
13D / 13G Filings
9
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
12.6%
Max % of class reported
Institutional Holders
4
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
9 filings · latest Jul 17, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jul 17, 2025 | Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas LLC | 13G | 5.8% | 2.14M | SEC |
| 2 | May 2, 2025 | Suvretta Capital Management, LLC | 13G | 10.6% | 4.28M | SEC |
| 3 | Oct 29, 2024 | Biotechnology Value Fund L P | 13D/A | 12.6% | 5.08M | SEC |
| 4 | Nov 20, 2023 | Biotechnology Value Fund L P | 13D | 12.3% | 4.49M | SEC |
| 5 | Nov 7, 2023 | Biotechnology Value Fund L P | 13G/A | 9.2% | 3.34M | SEC |
| 6 | Feb 14, 2023 | Biotechnology Value Fund L P | 13G/A | 6.8% | 2.41M | SEC |
| 7 | Jan 12, 2022 | Biotechnology Value Fund L P | 13G/A | 7.6% | 2.45M | SEC |
| 8 | Jan 12, 2022 | Biotechnology Value Fund L P | 13G/A | 4.9% | 1.58M | SEC |
| 9 | Sep 15, 2021 | Biotechnology Value Fund L P | 13G | 4.1% | 1.32M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Suvretta Capital Management, LLC | 2.22M | $8.82M |
| 2 | Bvf Inc/Il | 1.35M | $5.36M |
| 3 | Smartharvest Portfolios, LLC | 15.5K | $61.7K |
| 4 | Morgan Stanley | 367 | $1.5K |